FDA Inspection
Galephar Pharmaceutical Research Inc.Galephar Pharmaceutical Research Inc. – FDA Inspection, Nov 23, 2015
Record Details
This FDA Inspection record concerns Galephar Pharmaceutical Research Inc., with an inspection on November 23, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- November 23, 2015
- Product Type
- Drugs
View Company Profile
ID · dc3839f8-3bc3-4374-b07e-26dd85265f5b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 952658
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.198(a)Complaint Handling Procedure
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Galephar Pharmaceutical Research Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| October 18, 2024 | VAI | San Juan District Office | Drug Quality Assurance |
| October 24, 2018 | Not classified | San Juan District Office | |
| September 29, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 4, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 30, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Galephar Pharmaceutical Research Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.